Results 51 to 60 of about 113,140 (309)
Handling persistent cardiac troponin elevation in asymptomatic athletes: The role of macrocomplexes
Study objective: Return-to-play (RTP) decision includes cardiac troponin I returning to baseline. Formation of antibodies to cardiac troponin I (macrocomplexes) may lead to persistent, false positively elevated cardiac troponin I and may induce ...
Simon Wernhart +2 more
doaj +1 more source
OBJECTIVES: The aim of this study is to determine the imprecision profile, 99th percentile and diagnostic efficiency of a new high sensitivity cardiac troponin I (cTnI) assay. METHODS: Total imprecision was assessed by following CLSI protocol EP15-A.14.
Gaze, D.C., Collinson, P., Goodacre, S.
core +1 more source
CK2α Deficiency Drives Myocardial Fibrosis via Desmin‐Induced Mitochondrial Dysfunction
CK2α preserves mitochondrial homeostasis by phosphorylating Desmin to recruit Cryab, ensuring proper filament assembly. CK2α deficiency disrupts this interaction, causing mitochondrial dysfunction, metabolic shifts, bioenergetic failure, and oxidative stress—ultimately establishing a pro‐fibrotic environment that drives cardiac fibrosis.
Canjie Ma +12 more
wiley +1 more source
Prognostic prediction of troponins in cardiac myxoma: case study with literature review
Objective:It was supposed that troponins in cardiac myxoma patients might be in a same fashion as in the conditions without myocardial injury. In order to verify this hypothesis, troponins in cardiac myxoma patients were discussed by presenting a ...
Shi-Min Yuan
doaj +1 more source
Background and Objectives: This study aimed to evaluate the relationship between mortality and cardiac laboratory findings in patients who were hospitalized after a positive PCR for COVID-19 infection.
Sinem Özyılmaz +4 more
doaj +1 more source
Copyright information:Taken from "Troponin-I release after cardiac surgery with different surgical techniques and post-operative neurological outcomes"McGill Journal of Medicine : MJM 2006;9(2):88-94.Published online Jan 2006PMCID:PMC2323524.Copyright ©
Akhshay Kumar Bisoi (90849) +3 more
core +1 more source
ABSTRACT Doxorubicin‐induced cardiomyopathy (DIC) remains a dose‐limiting clinical challenge. This study reveals that cardiac vascular endothelial cells (CVECs) act as initial sensors of doxorubicin cardiotoxicity: circulating doxorubicin activates the cGAS‑STING pathway in CVECs, triggering NLRP3 inflammasome‑mediated pyroptosis and release of ...
Wang Jun +10 more
wiley +1 more source
Immunoadsorption and subsequent administration of intravenous immunoglobulin (IVIG) have shown beneficial effects on cardiac function and symptoms in patients with dilated cardiomyopathy. Biomarkers play an emerging role in disease monitoring and outcome
Karolina Weinmann +5 more
doaj +1 more source
Troponin I and myocardial injury in the ICU
Cardiac troponin I (cTnI) is a protein that is specific to heart muscle. Increased concentrations appear in serum after myocardial cell injury. cTnI was compared with creatinine kinase MB (CK MB), myoglobin and the 12-lead ECG for detection of myocardial injury in an unselected series of 109 medical and surgical ICU patients.
J S, Noble +4 more
openaire +2 more sources
Persistent False-Positive Troponin I Elevation Due to Heterophile Antibody Interference: A Case Report [PDF]
Troponins are important biomarkers in the diagnosis of acute coronary syndrome (ACS). In this case report, we present the clinical course of an 80-year-old female patient who presented with complaints of fever, sore throat, and fatigue.
Adem Adar +3 more
core +1 more source

